Masami Takeuchi

3.3k total citations
120 papers, 1.4k citations indexed

About

Masami Takeuchi is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Masami Takeuchi has authored 120 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Hematology, 36 papers in Oncology and 35 papers in Molecular Biology. Recurrent topics in Masami Takeuchi's work include Multiple Myeloma Research and Treatments (54 papers), Lymphoma Diagnosis and Treatment (34 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (22 papers). Masami Takeuchi is often cited by papers focused on Multiple Myeloma Research and Treatments (54 papers), Lymphoma Diagnosis and Treatment (34 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (22 papers). Masami Takeuchi collaborates with scholars based in Japan, Netherlands and Greece. Masami Takeuchi's co-authors include Kosei Matsue, Masayuki Yamakura, Noboru Asada, Kentaro Narita, Daisuke Miura, Akihiro Kitadate, Jun Odawara, Yoshiaki Abe, Hidetaka Uryu and Hiroki Kobayashi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Masami Takeuchi

115 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masami Takeuchi Japan 20 551 454 434 425 327 120 1.4k
Nabih Azar France 19 344 0.6× 245 0.5× 264 0.6× 295 0.7× 330 1.0× 41 1.3k
Carlos Grande Spain 18 504 0.9× 622 1.4× 151 0.3× 371 0.9× 96 0.3× 82 1.4k
Beenu Thakral United States 18 411 0.7× 348 0.8× 83 0.2× 499 1.2× 149 0.5× 114 1.2k
Nathalie Parquet France 21 261 0.5× 480 1.1× 98 0.2× 449 1.1× 332 1.0× 55 1.4k
Armando López‐Guillermo Spain 8 440 0.8× 338 0.7× 180 0.4× 818 1.9× 90 0.3× 10 1.5k
K Kawa Japan 21 506 0.9× 715 1.6× 166 0.4× 677 1.6× 133 0.4× 51 1.6k
Toshiki Yamada Japan 18 310 0.6× 336 0.7× 86 0.2× 441 1.0× 174 0.5× 61 1.1k
Alberto Fernández de Sevilla Spain 19 720 1.3× 743 1.6× 105 0.2× 84 0.2× 278 0.9× 51 1.4k
Joseph M. Wiley United States 19 168 0.3× 338 0.7× 150 0.3× 630 1.5× 200 0.6× 37 1.5k
Sanya Sukpanichnant Thailand 16 513 0.9× 393 0.9× 101 0.2× 90 0.2× 107 0.3× 54 930

Countries citing papers authored by Masami Takeuchi

Since Specialization
Citations

This map shows the geographic impact of Masami Takeuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masami Takeuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masami Takeuchi more than expected).

Fields of papers citing papers by Masami Takeuchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masami Takeuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masami Takeuchi. The network helps show where Masami Takeuchi may publish in the future.

Co-authorship network of co-authors of Masami Takeuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Masami Takeuchi. A scholar is included among the top collaborators of Masami Takeuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masami Takeuchi. Masami Takeuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ikeda, Daisuke, Hajime Sakuma, Rikako Tabata, et al.. (2024). Soluble B-cell maturation antigen levels for disease monitoring in oligosecretory and nonsecretory relapsed multiple myeloma. Blood. 145(5). 526–532. 5 indexed citations
2.
Ikeda, Daisuke, Toshiki Terao, Rikako Tabata, et al.. (2023). Analysis of baseline circulating tumor cells integrated with PET/CT findings in transplant-ineligible multiple myeloma. Blood Advances. 8(1). 37–46. 2 indexed citations
3.
Narita, Kentaro, Daisuke Ikeda, Rikako Tabata, et al.. (2023). Safety and efficacy of venetoclax for acute myeloid leukaemia in real-world clinical practice. Japanese Journal of Clinical Oncology. 53(10). 991–995. 2 indexed citations
4.
Takeuchi, Masami, et al.. (2023). Kidney involvement of chronic active Epstein‐Barr virus infection. SHILAP Revista de lepidopterología. 4(1). 278–279. 1 indexed citations
5.
Terao, Toshiki, Kentaro Narita, Daisuke Ikeda, et al.. (2023). Clinical Characteristics and Outcomes of Cyclin D1–Positive AL Amyloidosis. American Journal of Clinical Pathology. 160(2). 157–163. 2 indexed citations
6.
Terao, Toshiki, Youichi Machida, Kentaro Narita, et al.. (2021). Total diffusion volume in MRI vs. total lesion glycolysis in PET/CT for tumor volume evaluation of multiple myeloma. European Radiology. 31(8). 6136–6144. 16 indexed citations
8.
Terao, Toshiki, et al.. (2021). EBV-PTLD in a patient after haploidentical stem-cell transplantation with post-transplant cyclophosphamide. International Journal of Hematology. 114(1). 136–140. 2 indexed citations
9.
Miura, Daisuke, Kentaro Narita, Rikako Tabata, et al.. (2019). Clinical and Prognostic Impact of (11;14)(q13;q32) Translocation on Patients with Multiple Myeloma. Blood. 134(Supplement_1). 5507–5507. 1 indexed citations
10.
Abe, Yoshiaki, Kentaro Narita, Hiroki Kobayashi, et al.. (2019). 18F-FDG PET/CT-Guided Diagnosis and Evaluation of Treatment Response to Cyclosporine A in Maldistributed Subcutaneous Panniculitis-like T-Cell Lymphoma Without Typical Skin Rash. Clinical Nuclear Medicine. 45(2). e69–e71. 3 indexed citations
11.
12.
Abe, Yoshiaki, Kentaro Narita, Hiroki Kobayashi, et al.. (2017). Normalization of the Serum Free Light Chain Ratio in Patients with Intact Immunoglobulin Multiple Myeloma Who Achieve Less Than Complete Response. Blood. 130. 5380–5380. 1 indexed citations
13.
Suehara, Yasuhito, Mamiko Sakata‐Yanagimoto, Keiichiro Hattori, et al.. (2017). Liquid Biopsy for the Identification of Intravascular Large B-Cell Lymphoma. Blood. 130. 378–378. 6 indexed citations
15.
Narita, Kentaro, Hiroki Kobayashi, Yoshiaki Abe, Masami Takeuchi, & Kosei Matsue. (2017). Evaluation of Risk Factors and Survival Effect of Delayed Excretion of High-Dose Methotrexate in Patients with Leukemia and Lymphoma. Blood. 130. 4132–4132. 2 indexed citations
16.
Fujisawa, Manabu, Yasuhito Suehara, Kota Fukumoto, Masami Takeuchi, & Kosei Matsue. (2015). Changes in survival rate of multiple myeloma after the introduction of bortezomib: a single institutional experience over 20 years. Annals of Hematology. 95(1). 63–72. 8 indexed citations
18.
Yamakura, Masayuki, Shun‐ichi Kimura, Jun Odawara, et al.. (2008). Use of urine cytology in the diagnosis of genitourinary relapse of acute promyelocytic leukemia after allogenic stem cell transplant. International Journal of Hematology. 88(3). 251–252. 3 indexed citations
19.
Kimura, Shun‐ichi, Takatoshi Aoki, Jun Odawara, et al.. (2007). Primary amyloidosis associated with IgD-λ M-proteinemia. 48(12). 1555–1558. 1 indexed citations
20.
Matsue, Kosei, et al.. (2006). Breakthrough Trichosporonosis in Patients with Hematologic Malignancies Receiving Micafungin. Clinical Infectious Diseases. 42(6). 753–757. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026